Daiwa Securities Group’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16
| Closed | – | – | 1280 |
|
|
2024
Q4 | $0 | Sell |
16
-1
| -6% | -$9 | ﹤0.01% | 1284 |
|
|
2024
Q3 | $0 | Hold |
17
| – | – | ﹤0.01% | 1283 |
|
|
2024
Q2 | $0 | Sell |
17
-795
| -98% | -$15.9K | ﹤0.01% | 1321 |
|
|
2024
Q1 | $21K | Sell |
812
-52
| -6% | -$1.33K | ﹤0.01% | 1134 |
|
|
2023
Q4 | $24K | Sell |
864
-290
| -25% | -$17.7K | ﹤0.01% | 1115 |
|
|
2023
Q3 | $70K | Hold |
1,154
| – | – | ﹤0.01% | 1042 |
|
|
2023
Q2 | $76K | Buy |
1,154
+686
| +147% | +$50.2K | ﹤0.01% | 1046 |
|
|
2023
Q1 | $30K | Buy |
468
+89
| +23% | +$10.2K | ﹤0.01% | 1062 |
|
|
2022
Q4 | $52K | Buy |
379
+367
| +3,058% | +$51.7K | ﹤0.01% | 1033 |
|
|
2022
Q3 | $1K | Sell |
12
-1,111
| -99% | -$126K | ﹤0.01% | 1276 |
|
|
2022
Q2 | $93K | Buy |
1,123
+1,111
| +9,258% | +$86.2K | ﹤0.01% | 1032 |
|
|
2022
Q1 | $1K | Hold |
12
| – | – | ﹤0.01% | 1296 |
|
|
2021
Q4 | $2K | Sell |
12
-6
| -33% | -$1.42K | ﹤0.01% | 1275 |
|
|
2021
Q3 | $4K | Buy |
18
+8
| +80% | +$2.29K | ﹤0.01% | 1190 |
|
|
2021
Q2 | $4K | Hold |
10
| – | – | ﹤0.01% | 1083 |
|
|
2021
Q1 | $4K | Hold |
10
| – | – | ﹤0.01% | 1087 |
|
|
2020
Q4 | $5K | Sell |
10
-18
| -64% | -$11.4K | ﹤0.01% | 1055 |
|
|
2020
Q3 | $20K | Buy |
28
+4
| +17% | +$3.12K | ﹤0.01% | 990 |
|
|
2020
Q2 | $14K | Hold |
24
| – | – | ﹤0.01% | 1044 |
|
|
2020
Q1 | $14K | Hold |
24
| – | – | ﹤0.01% | 1031 |
|
|
2019
Q4 | $27K | Sell |
24
-3
| -11% | -$3.26K | ﹤0.01% | 994 |
|
|
2019
Q3 | $32K | Hold |
27
| – | – | ﹤0.01% | 976 |
|
|
2019
Q2 | $44K | Sell |
27
-299
| -92% | -$517K | ﹤0.01% | 970 |
|
|
2019
Q1 | $665K | Sell |
326
-154
| -32% | -$271K | 0.01% | 568 |
|
|
2018
Q4 | $617K | Sell |
480
-714
| -60% | -$1.1M | 0.01% | 546 |
|
|
2018
Q3 | $2.26M | Sell |
1,194
-4
| -0.3% | -$8.26K | 0.02% | 349 |
|
|
2018
Q2 | $2.44M | Buy |
1,198
+333
| +38% | +$759K | 0.02% | 344 |
|
|
2018
Q1 | $1.91M | Buy |
865
+59
| +7% | +$150K | 0.02% | 380 |
|
|
2017
Q4 | $1.86M | Sell |
806
-836
| -51% | -$1.7M | 0.01% | 394 |
|
|
2017
Q3 | $2.92M | Buy |
1,642
+338
| +26% | +$472K | 0.02% | 282 |
|
|
2017
Q2 | $1.77M | Buy |
+1,304
| New | +$1.57M | 0.01% | 345 |
|
Other funds holding BLUE
TCM
CIEC
GLF
EPM
QOP
Daiwa Securities Group's BLUE Position: Q1 2025 in Review
Daiwa Securities Group sold out of bluebird bio (BLUE) in Q1 2025, closing a stake of 16 shares.
Daiwa Securities Group first reported a position in BLUE in Q2 2017 and held it in 31 quarters. The position peaked at $2.92M in Q3 2017. 85 funds tracked by Wall St. Rank hold BLUE as of Q1 2025.
- Daiwa Securities Group reported no remaining bluebird bio position as of Q1 2025 after selling out during the quarter.
- Daiwa Securities Group sold 16 bluebird bio shares in Q1 2025.
- Daiwa Securities Group first reported a position in bluebird bio in Q2 2017 and held it in 31 quarters.
- Daiwa Securities Group's bluebird bio position peaked at $2.92M in Q3 2017.
- 85 funds tracked by Wall St. Rank held bluebird bio as of Q1 2025.
Based on Daiwa Securities Group's 13F filing for Q1 2025, filed 13 May 2025.